Willingness to pay in treatment of bleeding disorders.
This paper presents the results of a contingent valuation study measuring willingness to pay (WTP) for treatment of patients with von Willebrand's disease. Median WTP for treatment of this disorder was $1,500 or $3,500, depending on how the initial bid was structured. Regression analysis shows that income, education, and a category rating scale for health status were significant in predicting WTP. The adjusted annual WTP was $2,178. WTP surveys may increasingly be useful for health technology assessment. Starting point bias in how the bids are structured must be recognized.
George Washington University, USA.
S R
SR
Eastaugh
D001294:Attitude to Health; D003362:Cost-Benefit Analysis; D005252:Fees, Pharmaceutical; D005260:Female; D005382:Financing, Personal; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis; D012959:Socioeconomic Factors; D011795:Surveys and Questionnaires; D013673:Technology Assessment, Biomedical; D014481:United States; D014842:von Willebrand Diseases / Q000188:drug therapy* / Q000191:economics*